FSHB

mutation — cross-omics
Cross-omicsMUTATION → IMMUNEPatientPairwise association · TCGA cohorts

Across TCGA patient cohorts, FSHB mutation is significantly associated with the immune_cell of many other genes, with 3 significant associations in total. SKCM shows the largest number of these associations.

The most reproducible FSHB-associated genes across cancer lineages are Endothelial cells, CD4+ Tem, and Mast cells. Each is linked with FSHB in more than 1 cancer types. Because this analysis shows association rather than direction, both FSHB-to-partner and partner-to-FSHB results are reported.

Each partner links to its own Q-omics profile. The box plot shows the strongest example, Endothelial cells grouped by FSHB-low versus FSHB-high in SKCM.

mutation associated genes by consensus

Ranked by combined sampling and lineage consensus. X-score (FSHB→partner) and Y-score (partner→FSHB) are standardized regression coefficients; both directions are reported because the association is undirected. p-values are from the association test.
LineagePartner geneX-scoreY-scorep(X)p(Y)Sampling consensusLineage consensus
SKCMEndothelial cells →-0.041-2.974.023.03532
OVCD4+ Tem →+0.024+5.930<.001.03231
SKCMMast cells →+0.027+1.919.001.03031
Each partner links to its Q-omics profile. Showing the 3 strongest of 3 associations by consensus.

Endothelial cells by FSHB expression — SKCM

Box plot of Endothelial cells in FSHB-low vs FSHB-high samples in SKCM.

Explore this box plot interactively →

Exploration